AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Application programming interfaces (APIs) are no longer a niche technical concern; they are fundamental building blocks of modern business. From streamlining business processes and enabling external ...

New guidelines aim to streamline lifecycle management and adapt to scientific and technological advancements in drug development. Variations are classified into Type IA, Type IB, and Type II based on ...

EAST RUTHERFORD, N.J., Oct. 22, 2025 /CNW/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.